Annual EBIT
-$76.49 M
-$77.36 M-8902.53%
December 31, 2023
Summary
- As of February 26, 2025, BRNS annual earnings before interest & taxes is -$76.49 million, with the most recent change of -$77.36 million (-8902.53%) on December 31, 2023.
- During the last 3 years, BRNS annual EBIT has fallen by -$62.26 million (-437.25%).
- BRNS annual EBIT is now -8902.53% below its all-time high of $869.00 thousand, reached on December 31, 2022.
Performance
BRNS EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly EBIT
-$8.12 M
+$8.82 M+52.09%
September 30, 2024
Summary
- As of February 26, 2025, BRNS quarterly earnings before interest & taxes is -$8.12 million, with the most recent change of +$8.82 million (+52.09%) on September 30, 2024.
- Over the past year, BRNS quarterly EBIT has stayed the same.
- BRNS quarterly EBIT is now -154.90% below its all-time high of $14.78 million, reached on June 1, 2022.
Performance
BRNS Quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM EBIT
-$58.70 M
+$6.59 M+10.09%
September 30, 2024
Summary
- As of February 26, 2025, BRNS TTM earnings before interest & taxes is -$58.70 million, with the most recent change of +$6.59 million (+10.09%) on September 30, 2024.
- Over the past year, BRNS TTM EBIT has stayed the same.
- BRNS TTM EBIT is now -837.73% below its all-time high of $7.96 million, reached on September 1, 2022.
Performance
BRNS TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
EBIT Formula
EBIT = Revenue − COGS − Operating Expenses
BRNS EBIT Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -8902.5% | 0.0% | 0.0% |
| 3 y3 years | -437.3% | +62.0% | -3463.9% |
| 5 y5 years | - | +49.2% | -65.8% |
BRNS EBIT Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -8902.5% | at low | -154.9% | +67.5% | -837.7% | +26.4% |
| 5 y | 5-year | -8902.5% | at low | -154.9% | +67.5% | -837.7% | +26.4% |
| alltime | all time | -8902.5% | at low | -154.9% | +67.5% | -837.7% | +26.4% |
Barinthus Biotherapeutics EBIT History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$8.12 M(-52.1%) | -$58.70 M(-10.1%) |
| Jun 2024 | - | -$16.94 M(+9.0%) | -$65.29 M(-10.9%) |
| Mar 2024 | - | -$15.54 M(-14.1%) | -$73.30 M(-4.2%) |
| Dec 2023 | -$76.49 M(-8902.5%) | -$18.10 M(+23.1%) | -$76.49 M(-4.1%) |
| Sep 2023 | - | -$14.71 M(-41.0%) | -$79.72 M(+36.3%) |
| Jun 2023 | - | -$24.95 M(+33.1%) | -$58.51 M(+211.6%) |
| Mar 2023 | - | -$18.74 M(-12.2%) | -$18.78 M(-1176.2%) |
| Dec 2022 | $869.00 K | -$21.33 M(-427.6%) | $1.75 M(-78.1%) |
| Sep 2022 | - | $6.51 M(-55.9%) | $7.96 M(-354.1%) |
| Jun 2022 | - | $14.78 M(+728.1%) | -$3.13 M(-90.8%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2022 | - | $1.78 M(-111.8%) | -$33.89 M(-30.1%) |
| Dec 2021 | -$48.47 M(+240.4%) | - | - |
| Dec 2021 | - | -$15.12 M(+230.4%) | -$48.47 M(+17.8%) |
| Sep 2021 | - | -$4.58 M(-71.3%) | -$41.15 M(+16.2%) |
| Jun 2021 | - | -$15.97 M(+24.8%) | -$35.40 M(+53.3%) |
| Mar 2021 | - | -$12.80 M(+64.1%) | -$23.09 M(+62.2%) |
| Dec 2020 | -$14.24 M | -$7.80 M(-767.2%) | -$14.24 M(+121.1%) |
| Sep 2020 | - | $1.17 M(-132.0%) | -$6.44 M(-15.4%) |
| Jun 2020 | - | -$3.66 M(-7.4%) | -$7.61 M(+92.6%) |
| Mar 2020 | - | -$3.95 M | -$3.95 M |
FAQ
- What is Barinthus Biotherapeutics annual earnings before interest & taxes?
- What is the all time high annual EBIT for Barinthus Biotherapeutics?
- What is Barinthus Biotherapeutics annual EBIT year-on-year change?
- What is Barinthus Biotherapeutics quarterly earnings before interest & taxes?
- What is the all time high quarterly EBIT for Barinthus Biotherapeutics?
- What is Barinthus Biotherapeutics quarterly EBIT year-on-year change?
- What is Barinthus Biotherapeutics TTM earnings before interest & taxes?
- What is the all time high TTM EBIT for Barinthus Biotherapeutics?
- What is Barinthus Biotherapeutics TTM EBIT year-on-year change?
What is Barinthus Biotherapeutics annual earnings before interest & taxes?
The current annual EBIT of BRNS is -$76.49 M
What is the all time high annual EBIT for Barinthus Biotherapeutics?
Barinthus Biotherapeutics all-time high annual earnings before interest & taxes is $869.00 K
What is Barinthus Biotherapeutics annual EBIT year-on-year change?
Over the past year, BRNS annual earnings before interest & taxes has changed by -$77.36 M (-8902.53%)
What is Barinthus Biotherapeutics quarterly earnings before interest & taxes?
The current quarterly EBIT of BRNS is -$8.12 M
What is the all time high quarterly EBIT for Barinthus Biotherapeutics?
Barinthus Biotherapeutics all-time high quarterly earnings before interest & taxes is $14.78 M
What is Barinthus Biotherapeutics quarterly EBIT year-on-year change?
Over the past year, BRNS quarterly earnings before interest & taxes has changed by $0.00 (0.00%)
What is Barinthus Biotherapeutics TTM earnings before interest & taxes?
The current TTM EBIT of BRNS is -$58.70 M
What is the all time high TTM EBIT for Barinthus Biotherapeutics?
Barinthus Biotherapeutics all-time high TTM earnings before interest & taxes is $7.96 M
What is Barinthus Biotherapeutics TTM EBIT year-on-year change?
Over the past year, BRNS TTM earnings before interest & taxes has changed by $0.00 (0.00%)